Provided by Tiger Fintech (Singapore) Pte. Ltd.

ZYVERSA THERAPEUTICS INC

0.6100
-0.0090-1.45%
Post-market: 0.63920.0292+4.79%19:48 EDT
Volume:153.89K
Turnover:95.23K
Market Cap:2.21M
PE:-0.07
High:0.6324
Open:0.6300
Low:0.6032
Close:0.6190
Loading ...
Jul 07, 2023

Correspondence

Form CORRESP - Correspondence
Jul 07, 2023

Correspondence

Form CORRESP - Correspondence
Jul 07, 2023

Correspondence

Form CORRESP - Correspondence
Jun 30, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jun 30, 2023

Correspondence

Form CORRESP - Correspondence
Jun 15, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jun 12, 2023

Major Issues Report

Form 8-K - Current report
May 19, 2023

Major Issues Report

Form 8-K - Current report
May 19, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 15, 2023

Major Issues Report

Form 8-K - Current report
May 12, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 12, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 03, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Apr 25, 2023

Correspondence

Form CORRESP - Correspondence
Apr 25, 2023

Correspondence

Form CORRESP - Correspondence
Apr 24, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Apr 24, 2023

Correspondence

Form CORRESP - Correspondence
Apr 24, 2023

Correspondence

Form CORRESP - Correspondence
Apr 21, 2023

Correspondence

Form CORRESP - Correspondence